1286816

Dendreon Pharmaceuticals LLC — FEI 3008914686

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 29, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Union City, GA (United States)

Citations

IDCFRDescription
203121 CFR 211.194(a)Complete test data included in records
358521 CFR 211.110(a)Control procedures to monitor and validate performance